About Mitotax 300mg Injection
Mitotax 300mg Injection is an in-demand, prescription-only anticancer treatment marked by its distinguished efficacy. Supplied in a resplendent, clear solution vial (50 ml, 300 mg strength; no preservative), this single-dose formulation boasts an incomparable standard for hospital use. With Paclitaxel as its salt composition, Mitotax excels in treating breast and ovarian cancers via intravenous infusion (6 mg/ml concentration). Secure your Markdown pricing-Get It Now from leading exporters, suppliers, and traders throughout India. Always store below 25C, shielded from light, and refer to the packaging for the official shelf life.
Versatile Application and Adherence to Medical Protocol
Mitotax 300mg Injection is designed for intravenous use only, ensuring controlled, precise delivery directly into the bloodstream. Its application areas include treatment of various cancers such as breast and ovarian, making it highly valued in oncology departments. This clear, preservative-free solution is provided in a single-dose vial, promoting safety and convenience for both patient and healthcare professional. Packaged for hospital use, it meets stringent standards for sterile administration and storage.
Premium Payment Options and Reliable Supply Delivered Globally
Mitotax 300mg Injection comes from a distinguished supplier network, offering premium payment terms in line with international standards. Certified for quality, this product's supply ability meets the demands of hospitals and clinics worldwide. Each order is meticulously handled to ensure products are delivered promptly and securely. As a premium anticancer injectable, Mitotax maintains compliance, reliability, and consistent global availability so healthcare providers can administer it with confidence.
FAQ's of Mitotax 300mg Injection:
Q: How is Mitotax 300mg Injection administered?
A: Mitotax 300mg Injection must be administered by a healthcare professional as an intravenous infusion, ensuring direct delivery into the bloodstream for effective cancer treatment.
Q: What are the primary indications for using Mitotax 300mg Injection?
A: This injection is primarily indicated for the treatment of several cancers, particularly breast and ovarian cancer, as well as other oncological conditions as advised by a physician.
Q: When should Mitotax 300mg Injection be used?
A: Mitotax 300mg Injection is used upon prescription by a medical specialist, typically as part of a hospital's chemotherapy protocols involving confirmed diagnosis of applicable cancers.
Q: Where should Mitotax 300mg Injection be stored?
A: Store the vial below 25C in a dry place and protect it from light. Refer to the packaging for the exact shelf life before use.
Q: What are the benefits of the single dose vial packaging of Mitotax 300mg Injection?
A: The single dose vial format enhances patient safety by reducing contamination risk and simplifying dosage accuracy during administration.